Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study focuses on analyzing the data collected from participants in the Faculty/Staff Exercise Program to determine the success and quantifying the results of the program. The investigators are interested in the effectiveness of this program on multiple levels, individual and group, as it is the first of its kind - an exercise program targeting the faculty and staff at a university.
This study focuses on analyzing the data collected from participants in the Faculty/Staff Exercise Program to determine the success and quantifying the results of the program. The investigators are interested in the effectiveness of this program on multiple levels, individual and group, as it is the first of its kind - an exercise program targeting the faculty and staff at a university. Participants were regular attendees in either a 6am or 12pm exercise program session. Data included both measures of physical health as well as cognitive health. Measures of physical health included the assessment of body fat using the skin-fold method of analysis (3-site). Cholesterol was measured via blood draw analysis. This was done at the Kent State University Exercise Physiology Laboratory by certified research staff. A 6 minute walk test was completed to measure aerobic capacity. Flexibility was assessed via the sit-and-reach test while anaerobic strength and endurance were assessed using sit-up and curl-up tests. Assessment of balance was done using a Biodex Balance System.
Assessments of cognitive health included several questionnaires that asked questions related to sleep habits, stress levels, and mood. In addition, each participant was given a MOVband to track physical activity. The device was worn during waking hours for all days of participation.The data from the MOVband was auto-uploaded to a computer program for tracking so that no manual entry was necessary.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Physical Activity | Experimental | Participants were subjected to a 12-week exercise program targeting the federal physical activity guidelines. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Physical Activity | Behavioral | Participants underwent 12-weeks of exercise prescription aimed at the federal guidelines (3 days/week). |
|
| Measure | Description | Time Frame |
|---|---|---|
| Height | Objectively measured height in meters using a standard clinical stadiometer. | Assessed once at baseline. |
| Weight | Objectively measured weight in kilograms using a standard clinical scale. | Change from baseline weight at 4-weeks, 8-weeks, and 12-weeks follow-up. |
| Systolic Blood Pressure | Objectively measured systolic blood pressure in millimeters of Mercury using a standard Mercury sphygmomanometer. | Change from baseline systolic blood pressure at 4-weeks, 8-weeks, and 12-weeks follow-up. |
| Diastolic Blood Pressure | Objectively measured diastolic blood pressure in millimeters of Mercury using a standard Mercury sphygmomanometer. | Change from baseline diastolic blood pressure at 4-weeks, 8-weeks, and 12-weeks follow-up. |
| High-Density Lipoprotein | Objectively measured high-density lipoprotein in milligrams per deciliter using a standard assay kit. | Change from baseline high-density lipoprotein at 4-weeks, 8-weeks, and 12-weeks follow-up. |
| Low-Density Lipoprotein | Objectively measured low-density lipoprotein in milligrams per deciliter using a standard assay kit. | Change from baseline low-density lipoprotein at 4-weeks, 8-weeks, and 12-weeks follow-up. |
| Total Serum Cholesteral | Objectively measured total serum cholesterol in milligrams per deciliter using a standard assay kit. |
| Measure | Description | Time Frame |
|---|---|---|
| Accelerometer-Based Physical Activity | Assessment of accelerometer-based physical activity outcome measures (e.g., steps per day). | Change from baseline accelerometer-based physical activity 4-weeks, 8-weeks, and 12-weeks follow-up using 1-minute epochs. |
| Measure | Description | Time Frame |
|---|---|---|
| Sleep Quality (Pittsburgh Sleep Quality Index) | The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval. | Change from baseline sleep quality at 4-weeks, 8-weeks, and 12-weeks follow-up. |
| Depression (Depression, Anxiety, and Stress Scale-21) |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Duane B Corbett, PhD | Kent State University | Study Director |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29378632 | Derived | Corbett DB, Fennell C, Peroutky K, Kingsley JD, Glickman EL. The effects of a 12-week worksite physical activity intervention on anthropometric indices, blood pressure indices, and plasma biomarkers of cardiovascular disease risk among university employees. BMC Res Notes. 2018 Jan 29;11(1):80. doi: 10.1186/s13104-018-3151-x. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D057185 | Sedentary Behavior |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Change from baseline total serum cholesterol at 4-weeks, 8-weeks, and 12-weeks follow-up. |
| Impaired Fasting Glucose | Objectively measured impaired fasting glucose in milligrams per deciliter using a standard assay kit. | Change from baseline impaired fasting glucose at 4-weeks, 8-weeks, and 12-weeks follow-up. |
The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress. |
| Change from baseline depression at 4-weeks, 8-weeks, and 12-weeks follow-up. |
| Anxiety (Depression, Anxiety, and Stress Scale-21) | The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress. | Change from baseline anxiety at 4-weeks, 8-weeks, and 12-weeks follow-up. |
| Stress (Depression, Anxiety, and Stress Scale-21) | The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress. | Change from baseline stress at 4-weeks, 8-weeks, and 12-weeks follow-up. |
| Mood (Profile of Mood States) | The Profile of Mood States (POMS) is a psychological rating scale used to assess transient, distinct mood states. | Change from baseline mood at 4-weeks, 8-weeks, and 12-weeks follow-up. |
| Quality of Life (36-Item Short Form Survey) | The 36-item short form survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures. | Change from baseline quality of life at 4-weeks, 8-weeks, and 12-weeks follow-up. |